Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Virchow Medical is a precision oncology company that operates the Virchow Vault, the world's first liquid specimen biorepository. The company's core technology, the Crow's Nest Biopsy Catchment System, captures dislodged tumor cells from used biopsy needles that would otherwise be discarded as medical waste. These cells are processed into Liquid Companion Specimens (LCSs) and stored in the Virchow Vault, a CAP-accredited facility. This platform allows oncologists to order genomic sequencing and molecular testing even when traditional tissue blocks are insufficient or exhausted. By providing high-quality genetic material and a streamlined digital portal, Virchow Medical supports clinical decision-making, biomarker discovery, and the development of targeted therapies for biopharma partners.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Virchow Vault.